Synthetic and nonnatural oligonucleotides have been used extensively to interrogate gene function in zebrafish. In this review, we survey the capabilities and limitations of various oligonucleotide-based technologies for perturbing RNA function and tracking RNA expression. We also examine recent strategies for achieving spatiotemporal control of oligonucleotide function, particularly light-gated technologies that exploit the optical transparency of zebrafish embryos.
Get full access to this article
View all access options for this article.
References
1.
ShestopalovIA, ChenJK. Chemical technologies for probing embryonic development. Chem Soc Rev, 2008; 37:1294–1307.
2.
NeumannCJ, GrandelH, GaffieldW, Schulte-MerkerS, Nusslein-VolhardC. Transient establishment of anteroposterior polarity in the zebrafish pectoral fin bud in the absence of sonic hedgehog activity. Development, 1999; 126:4817–4826.
3.
YuPB, HongCC, SachidanandanC, BabittJL, DengDY, HoyngSAet al.Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol, 2008; 4:33–41.
4.
MorcosPA. Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos. Biochem Biophys Res Commun, 2007; 358:521–527.
5.
EsauCC. Inhibition of microRNA with antisense oligonucleotides. Methods, 2008; 44:55–60.
6.
SummertonJ, WellerD. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev, 1997; 7:187–195.
7.
EgholmM, BuchardtO, ChristensenL, BehrensC, FreierSM, DriverDAet al.PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature, 1993; 365:566–568.
8.
SummertonJ. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta, 1999; 1489:141–158.
KloostermanWP, LagendijkAK, KettingRF, MoultonJD, PlasterkRH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol, 2007; 5:e203.
BillBR, PetzoldAM, ClarkKJ, SchimmentiLA, EkkerSC. A primer for morpholino use in zebrafish. Zebrafish, 2009; 6:69–77.
13.
KamachiY, OkudaY, KondohH. Quantitative assessment of the knockdown efficiency of morpholino antisense oligonucleotides in zebrafish embryos using a luciferase assay. Genesis, 2008; 46:1–7.
14.
OuyangX, ShestopalovIA, SinhaS, ZhengG, PittCL, LiWHet al.Versatile synthesis and rational design of caged morpholinos. J Am Chem Soc, 2009; 131:13255–13269.
HutchinsonSA, EisenJS. Islet1 and Islet2 have equivalent abilities to promote motoneuron formation and to specify motoneuron subtype identity. Development, 2006; 133:2137–2147.
17.
UrtishakKA, ChoobM, TianX, SternheimN, TalbotWS, WickstromEet al.Targeted gene knockdown in zebrafish using negatively charged peptide nucleic acid mimics. Dev Dyn, 2003; 228:405–413.
18.
MaegawaS, VargaM, WeinbergES. FGF signaling is required for {beta}-catenin-mediated induction of the zebrafish organizer. Development, 2006; 133:3265–3276.
19.
ManoharanM. 2′-Carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation. Biochim Biophys Acta, 1999; 1489:117–130.
KrutzfeldtJ, RajewskyN, BraichR, RajeevKG, TuschlT, ManoharanMet al.Silencing of microRNAs in vivo with “antagomirs”Nature, 2005; 438:685–689.
22.
TomasiniAJ, SchulerAD, ZebalaJA, MayerAN. PhotoMorphs: a novel light-activated reagent for controlling gene expression in zebrafish. Genesis, 2009; 47:736–743.
23.
KloostermanWP, WienholdsE, KettingRF, PlasterkRH. Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Res, 2004; 32:6284–6291.
24.
BlidnerRA, SvobodaKR, HammerRP, MonroeWT. Photoinduced RNA interference using DMNPE-caged 2′-deoxy-2′-fluoro substituted nucleic acids in vitro and in vivo. Mol Biosyst, 2008; 4:431–440.
25.
FireAZ. Gene silencing by double-stranded RNA (Nobel Lecture)Angew Chem Int Ed Engl, 2007; 46:6966–6984.
26.
CarthewRW, SontheimerEJ. Origins and mechanisms of miRNAs and siRNAs. Cell, 2009; 136:642–655.
27.
WienholdsE, KoudijsMJ, van EedenFJ, CuppenE, PlasterkRH. The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nat Genet, 2003; 35:217–218.
28.
ZhaoZ, CaoY, LiM, MengA. Double-stranded RNA injection produces nonspecific defects in zebrafish. Dev Biol, 2001; 229:215–223.
29.
OatesAC, BruceAE, HoRK. Too much interference: injection of double-stranded RNA has nonspecific effects in the zebrafish embryo. Dev Biol, 2000; 224:20–28.
30.
GantierMP, WilliamsBR. The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev, 2007; 18:363–371.
LiYX, FarrellMJ, LiuR, MohantyN, KirbyML. Double-stranded RNA injection produces null phenotypes in zebrafish. Dev Biol, 2000; 217:394–405.
33.
WargeliusA, EllingsenS, FjoseA. Double-stranded RNA induces specific developmental defects in zebrafish embryos. Biochem Biophys Res Commun, 1999; 263:156–161.
34.
GruberJ, ManningaH, TuschlT, OsbornM, WeberK. Specific RNAi mediated gene knockdown in zebrafish cell lines. RNA Biol, 2005; 2:101–105.
35.
WangN, SunYH, LiuJ, WuG, SuJG, WangYPet al.Knock down of gfp and no tail expression in zebrafish embryo by in vivo-transcribed short hairpin RNA with T7 plasmid system. J Biomed Sci, 2007; 14:767–776.
36.
SuJ, ZhuZ, WangY, XiongF, ZouJ. The cytomegalovirus promoter-driven short hairpin RNA constructs mediate effective RNA interference in zebrafish in vivo. Mar Biotechnol (NY), 2008; 10:262–269.
37.
YangSL, YanS, NiuRL, LinXK. VEGF gene silencing by cytomegalovirus promoter driven shRNA expression vector results in vascular development defects in zebrafish. Genetika, 2009; 45:1187–1193.
38.
SuJ, ZhuZ, XiongF, WangY. Hybrid cytomegalovirus-U6 promoter-based plasmid vectors improve efficiency of RNA interference in zebrafish. Mar Biotechnol (NY), 2008; 10:511–517.
39.
DongM, FuYF, DuTT, JingCB, FuCT, ChenYet al.Heritable and lineage-specific gene knockdown in zebrafish embryo. PLoS One, 2009; 4:e6125.
40.
AndoH, FurutaT, TsienRY, OkamotoH. Photo-mediated gene activation using caged RNA/DNA in zebrafish embryos. Nat Genet, 2001; 28:317–325.
41.
ShahS, RangarajanS, FriedmanSH. Light-activated RNA interference. Angew Chem Int Ed Engl, 2005; 44:1328–1332.
42.
LusicH, YoungDD, LivelyMO, DeitersA. Photochemical DNA activation. Org Lett, 2007; 9:1903–1906.
43.
YoungDD, LusicH, LivelyMO, YoderJA, DeitersA. Gene silencing in mammalian cells with light-activated antisense agents. Chembiochem, 2008; 9:2937–2940.
TangX, MaegawaS, WeinbergES, DmochowskiIJ. Regulating gene expression in zebrafish embryos using light-activated, negatively charged peptide nucleic acids. J Am Chem Soc, 2007; 129:11000–11001.
46.
ThisseC, ThisseB. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc, 2008; 3:59–69.
47.
JowettT. Double in situ hybridization techniques in zebrafish. Methods, 2001; 23:345–358.
48.
MosesJE, MoorhouseAD. The growing applications of click chemistry. Chem Soc Rev, 2007; 36:1249–1262.
49.
GramlichPM, WirgesCT, GierlichJ, CarellT. Synthesis of modified DNA by PCR with alkyne-bearing purines followed by a click reaction. Org Lett, 2008; 10:249–251.
50.
WengelJ. Synthesis of 3′-C- and 4′-C-branched oligodeoxynucleotides and the development of locked nucleic acid (LNA)Acc Chem Res, 1999; 32:301–310.
51.
WienholdsE, KloostermanWP, MiskaE, Alvarez-SaavedraE, BerezikovE, de BruijnEet al.MicroRNA expression in zebrafish embryonic development. Science, 2005; 309:310–311.
52.
KloostermanWP, WienholdsE, de BruijnE, KauppinenS, PlasterkRH. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat Methods, 2006; 3:27–29.
53.
JulianoR, AlamMR, DixitV, KangH. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res, 2008; 36:4158–4171.
54.
MoultonJD, JiangS. Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules, 2009; 14:1304–1323.
55.
KimS, RadhakrishnanUP, RajpurohitSK, KulkarniV, JagadeeswaranP. Vivo-Morpholino knockdown of alphaIIb: a novel approach to inhibit thrombocyte function in adult zebrafish. Blood Cells Mol Dis, 2009; 44:169–174.
56.
JulianoR, BaumanJ, KangH, MingX. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm, 2009; 6:686–695.
